HDV Screening Study

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

NCT00476723 ·Status: COMPLETED

HIV-HBV Co-Infection and Liver Disease

NCT00637429 ·Status: UNKNOWN

Towards a Functional Cure for HBV - The COMMIT Cohort Study

NCT03645044 ·Status: ACTIVE_NOT_RECRUITING

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

NCT00531167 ·Status: COMPLETED ·Phase: PHASE4

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

NCT02069678 ·Status: COMPLETED

Study of Safety and Tolerability of DCR HBVS

NCT03772249 ·Status: COMPLETED ·Phase: PHASE1

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

NCT00158717 ·Status: COMPLETED

Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection

NCT03854630 ·Status: UNKNOWN ·Phase: PHASE4

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

NCT01594905 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

NCT02967939 ·Status: COMPLETED ·Phase: PHASE3

Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

NCT05770895 ·Status: COMPLETED ·Phase: PHASE1

Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea

NCT02951364 ·Status: COMPLETED

Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases

NCT02049736 ·Status: WITHDRAWN ·Phase: NA

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

NCT01023230 ·Status: COMPLETED ·Phase: PHASE1

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

NCT01813487 ·Status: COMPLETED ·Phase: NA

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

NCT07096193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

NCT05957380 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB

NCT02615639 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

NCT00117533 ·Status: UNKNOWN ·Phase: PHASE4

Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus

NCT03695029 ·Status: UNKNOWN ·Phase: PHASE4

Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814

NCT00403585 ·Status: COMPLETED ·Phase: PHASE4

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

NCT01590615 ·Status: COMPLETED

Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women

NCT02044068 ·Status: COMPLETED

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

NCT06338826 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir

NCT02511431 ·Status: COMPLETED ·Phase: PHASE2